Neuromuscular Blockade Clinical Trial
Official title:
The Comparison of the TOF Cuff Monitor® With the TOF Watch SX® Monitor:
Neuromuscular blocking agents (NMBAs) are frequently used in anesthesia and quantitative neuromuscular monitoring is standard care. The TOF WATCH SX® monitor is considered as one of the reference monitoring devices in clinical research and clinical practice. With this monitor the ulnar nerve is stimulated at the wrist and the force of the movement of the thumb is measured with acceleromyography. This method requires freedom of movement of the patient's thumb. Unfortunately this is not always possible due to the constraints of patient positioning during the operation. The TOF Cuff® monitor is a modified non-invasive blood pressure cuff that incorporates stimulating electrodes in its inner surface and is based on the stimulation of the peripheral nerve in the arm (brachial plexus, ulnar and median nerves principally). The evoked neuromuscular activity is recorded through the changes in pressure generated in the inner part of the cuff by the muscular activity after the stimulus. Moreover, this device can be used for non-invasive reading of the blood pressure. This device has been validated with mechanomyography, but was never been compared with acceleromyography, which is the most common used neuromuscular monitoring method.
Neuromuscular blocking agents (NMBAs) are frequently used in anesthesia for tracheal
intubation, artificial ventilation, and continued muscle relaxation during surgical
interventions. It is of particular importance to measure the neuromuscular block for several
reasons:
1. To monitor the onset of neuromuscular block and to intubate when deep muscular
relaxation is attained.
2. To choose the best antagonist and its dosage dependent of the degree of neuromuscular
block (for instance sugammadex for deep neuromuscular block or neostigmine for
superficial block).
3. To avoid antagonization of neuromuscular block in the case of complete recovery of
neuromuscular function.
It is proven that monitoring of neuromuscular block reduces patient mortality. It avoids
postoperative residual curarization, which is associated with complications such as
hypoxemia, bronchoaspiration and pneumonia. Therefore the development and validation of new
and efficacious neuromuscular monitoring devices is of great importance.
Neuromuscular monitoring is done by stimulating with an electric current a nerve and to
measure the response of the corresponding muscle. In clinical practice acceleromyography is
the most often used quantitative measurement method, because it is much easier to apply than
other established quantitative neuromuscular monitoring methods such as mechanomyograpy and
electromyography. Acceleromyography is based on the piezoelectric effect where mechanical
forces at play on the surfaces of certain materials, such as crystals or ceramics, induce an
electrical current. According to Newton's second law of motion, force equals mass times
acceleration (F=m x a). At constant mass, the acceleration measured and the voltage thereby
generated can be used to derive the force of the stimulated muscle. It is standard practice
to stimulate the ulnar nerve at the wrist and to measure the movement of the adductor
pollicis. In the research setting acceleromyography (TOF Watch SX® monitor) is an established
and widely used method. This method requires freedom of movement of the patient's thumb.
Unfortunately this is not always possible due to the constraints of patient positioning
during the operation. The TOF Cuff® monitor is a modified non-invasive blood pressure cuff
that incorporates stimulating electrodes in its inner surface and is based on the stimulation
of the peripheral nerve in the arm (brachial plexus, ulnar and median nerves principally).
The evoked neuromuscular activity is recorded through the changes in pressure generated in
the inner part of the cuff by the muscular activity after the stimulus. Moreover, this device
can be used for non-invasive reading of the blood pressure. This device has been validated
with mechanomyography, but was never been compared with acceleromyography, which is the most
common used neuromuscular monitoring method.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05558969 -
The Effect of Magnesium Use in Reversal of Neuromuscular Block With Sugammadex
|
N/A | |
Completed |
NCT03168308 -
Sugammadex vs. Neostigmine for Neuromuscular Blockade Reversal in Thoracic Surgical Patients
|
Phase 4 | |
Not yet recruiting |
NCT03978780 -
Erector Spinae Block vs. Placebo Block Study
|
N/A | |
Completed |
NCT02912039 -
Electromyographic Assessment of the TetraGraph in Normal Volunteers
|
||
Completed |
NCT02892045 -
Mindray Neuromuscular Transmission Transducer
|
||
Completed |
NCT03427385 -
Minimum Local Anesthetic Dose for Adductor Canal Block
|
N/A | |
Completed |
NCT01450813 -
The Effect of Neuromuscular Blockade on the Composite Variability Index (CVI) During Laryngoscopy
|
N/A | |
Completed |
NCT00535496 -
Relation Between TOF-Watch® SX and a Peripheral Nerve Stimulator After 4.0 mg.Kg-1 Sugammadex (P05698)
|
Phase 3 | |
Recruiting |
NCT05794503 -
Postoperative Urinary Retention After Reversal of Neuromuscular Block by Neostigmine Versus Sugammadex
|
Early Phase 1 | |
Not yet recruiting |
NCT05993390 -
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
|
N/A | |
Recruiting |
NCT04609410 -
Bleeding in Laparoscopic Liver Surgery
|
N/A | |
Terminated |
NCT03649672 -
The Validity and Tolerability of Awake Calibration of the TOF Watch SX Monitor
|
N/A | |
Completed |
NCT05474638 -
Comparison of Mechanomyographic 100 Versus 200 Hz 5 Second Tetanic Fade Ratios During Neuromuscular Block Recovery
|
N/A | |
Completed |
NCT05687253 -
Evaluation of Intubation Conditions Following BX1000 or Rocuronium in Subjects Undergoing Surgery
|
Phase 2 | |
Completed |
NCT05120999 -
Comparison of Onset of Neuromuscular Blockade With Electromyographic and Acceleromyographic Monitoring
|
||
Completed |
NCT03608436 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Early Quality of Recovery
|
Phase 4 | |
Completed |
NCT03572413 -
The Effect of Low Pressure Pneumoperitoneum During Laparoscopic Colorectal Surgery on Innate Immune Homeostasis.
|
Phase 4 | |
Recruiting |
NCT02930629 -
Residual Block in Postoperative Anaesthetic Care Unit
|
N/A | |
Completed |
NCT02932254 -
Magnesium Sulfate Effect Following the Reversal of Neuromuscular Blockade Induced by Rocuronium With Sugammadex
|
Phase 4 | |
Completed |
NCT01828385 -
Effect of Magnesium on the Recovery Time of Neuromuscular Blockade With Sugammadex
|
Phase 4 |